Citations

Showing 10 of 108081 citations.

Lack of publication bias in randomized clinical trials (RCTs) sponsored by the National Cancer Institute (NCI) and performed by Cooperative Oncology Groups (COGs)
Daniels, Stephanie, Buckner, Jan C. , Swann, S., Smith, Roy E., Khyatat, A., Wells, Robert J., Djulbegović, Benjamin , Soares, Heloisa P. , Kumar, Ambuj , Daniels, S., Sargent, Daniel J.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 6004-6004

10.1200/jco.2004.22.90140.6004 Get It

High dose intra-arterial cisplatin with concomitant accelerated radiotherapy for patients with T4 and selected T3, N0–3, M0 head and neck cancer
Foote, Robert L. , Kasperbauer, Jan L. , Okuno, Scott H. , Nichols, D A, Brown, Paul D. , Garces, Yolanda I. , Strome, Scott E. , Sargent, Daniel J.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5528-5528

10.1200/jco.2004.22.90140.5528 Get It

Assessment of quality of life (QOL) in MA.17, a randomized placebo-controlled trial of letrozole in postmenopausal women following five years of tamoxifen
Whelan, Timothy J. , Goss, Paul E. , Ingle, JN, Pater, Joseph L. , Shepherd, Lois E. , Palmer, Michael , Robert, Nicholas J. , Martino, Silvana, Muss, Hyman B. , Tu, Dongsheng , Whelan, Timothy J

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 517-517

10.1200/jco.2004.22.90140.517 Get It

An ex vivo chemoresponse assay predicts carboplatin-induced progression-free interval in ovarian cancer
Coleman, Rob, Herzog, Thomas J. , Hosford, S., Sevin, Bernd‐Uwe, Fiori, L., Gallion, Holly H., Wells, Alan

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5134-5134

10.1200/jco.2004.22.90140.5134 Get It

Ex vivo chemoresponse assay of ovarian cancers predicts clinical outcome
Gallion, Holly H., Wa, Christopherson, Coleman, Rob, Herzog, Thomas J. , Sevin, Bernd‐Uwe, Fiori, L., Wells, Alan

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5074-5074

10.1200/jco.2004.22.90140.5074 Get It

Heterogeneity in chemoresponsiveness of ovarian cancer as demonstrated by an ex vivo chemo response assay
Ochs, Robert, Gallion, Holly H., Coleman, Rob, Herzog, Thomas J. , Sevin, B.U., Schellhas, Helmut F., Wells, Alan

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5059-5059

10.1200/jco.2004.22.90140.5059 Get It

Preliminary evidence of relationship between genetic markers and oncology patient quality of life (QOL)
Sloan, Jeffrey A., McLeod, H. L., Zhao, Xingping , Ramanathan, Ramesh K., Findlay, B., Morton, Roscoe F., Goldberg, Richard M. , Sargent, Daniel J. , Zhao, X., Fuchs, C., Williamson, Stephen K.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5-5

10.1200/jco.2004.22.90140.5 Get It

Radiofrequency ablation as an alternative treatment for renal carcinoma in the elderly
Tan, Winston , Fumagalli, Ricardo Paz

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 4709-4709

10.1200/jco.2004.22.90140.4709 Get It

Quality of life (QOL) and pain in advanced stage prostate cancer: impact of missing data on evaluating palliation in SWOG 9916
Moinpour, Carol M. , Vinson, Liara, Lara, Primo N. , Taplin, Mary‐Ellen , Burch, Patrick, Petrylak, Daniel P. , Berry, Donna Lynn , Jiang, Chen , Lanier, Stephen M. , Crawford, Emily D.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 4579-4579

10.1200/jco.2004.22.90140.4579 Get It

Low dose interferon-α2b (IFN) + thalidomide (T) in patients (pts) with previously untreated renal cell cancer (RCC). Improvement in progression-free survival (PFS) but not quality of life (QoL) or overall survival (OS). A phase III study of the Eastern Coo
Manola, Judith , Fairclough, Diane L., Cella, David , Richardson, Ronald L., Sosman, Jeffrey A. , Kasimis, Basil, Wilding, George, Gordon, Michael Solomon , Dutcher, Janice P.

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 4516-4516

10.1200/jco.2004.22.90140.4516 Get It